ANCO’s ASCO Highlights 2019

 

ANCO’s ASCO Highlights 2019
K

ANCO's ASCO Update: NIVO + IPI - New First-Line Therapy for Asymptomatic Melanoma Brain Metastases?

By ANCO’s ASCO Highlights 2019 FEATURING Katy K. Tsai
By ANCO’s ASCO Highlights 2019 FEATURING Katy K. Tsai
0 views
September 12, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

09:36
Johnson & Johnson

Mechanisms of Resistance in Locally Advanced or Metastatic EGFR+ NSC…

Feat. J. Heymach, M. Das

Featured Video

06:27
Johnson & Johnson

Challenges to Navigate in Locally Advanced or Metastatic EGFR+ NSCLC

Feat. M. Socinski, D. Waterhouse
Skin
10:10
ANCO’s ASCO Highlights 2019

ANCO's ASCO Update: NIVO + IPI - New First-Line Therapy for Asy…

Feat. K. Tsai
08:19
ANCO’s ASCO Highlights 2019

ANCO's ASCO Update: Adjuvant Whole-Brain Radiotherapy Not Recom…

Feat. K. Tsai
10:31
ANCO’s ASCO Highlights 2019

ANCO's ASCO 2019: Is Neoadjuvant Therapy Suited for Melanoma?

Feat. K. Tsai